Detalhe da pesquisa
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439329
2.
Tagraxofusp in myeloid malignancies.
Hematol Oncol
; 42(1): e3234, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846131
3.
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Hematol Oncol
; 42(1): e3249, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287529
4.
Teclistamab-cqyv in multiple myeloma.
Eur J Haematol
; 112(3): 320-327, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848191
5.
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
Eur J Haematol
; 112(6): 860-869, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294126
6.
Myelodysplastic syndromes with ring sideroblasts.
Hematol Oncol
; 41(4): 612-620, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794650
7.
Iron chelation therapy.
Eur J Haematol
; 110(5): 490-497, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708354
8.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
9.
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Haematologica
; 107(4): 921-932, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951891
10.
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
Hematol Oncol
; 40(5): 962-975, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961859
11.
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells.
Hematol Oncol
; 40(1): 40-47, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34679195
12.
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Hematol Oncol
; 40(5): 1009-1019, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638723
13.
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Eur J Haematol
; 108(3): 178-189, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716957
14.
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.
J Transl Med
; 19(1): 489, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852840
15.
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.
Haematologica
; 106(10): 2598-2612, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855274
16.
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol.
Eur J Haematol
; 106(6): 831-835, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662164
17.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
18.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol
; 189(5): 853-859, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064595
19.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
Haematologica
; 105(6): 1613-1620, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582547
20.
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.
Biol Blood Marrow Transplant
; 24(2): 406-409, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032267